S. Louis Bridges Jr., M.D., Ph.D., will succeed Robert P. Kimberly, M.D., as director of the Comprehensive Arthritis, Musculoskeletal & Autoimmunity Center.
David Chaplin, M.D., Ph.D., to the new position in the School of Medicine aimed at increasing development opportunities for faculty.
In this preliminary analysis, the first human study treatment neither built up in organs nor destroyed the bone marrow’s ability to make blood cells.
New marker predicts how resistant each patient’s brain cancer will be to chemotherapy.
The newly-renovated facility opened to improve patient health, comfort and convenience by making treatments available in one building.
UAB researchers have identified a set of experimental drugs called LRRK2 inhibitors that may go beyond symptom relief to directly counter the inflammation and nerve cell death at the root of Parkinson’s disease.
Genetic changes that protected their ancestors against fly-borne parasites may partly explain why African-Americans with lupus are up to five times more likely to develop end-stage kidney disease than those of European descent. This was the conclusion of a study presented this week at the American College of Rheumatology Scientific Sessions in Washington, D.C.